Beruflich Dokumente
Kultur Dokumente
Europe
international business
| 1
| 2
Year of Establishment
Commercial Production
Status
Type of Business
Product Categories
Dosage Forms
Number of Employees
Export Activities
| 3
| 4
VISION
MISSION
OBJECTIVE
| 5
THE JOURNEY
| 6
1986
1990
1998
2000
2001
2002
2003
2004
2005
| 7
2006
| 8
| 9
R&D
| 10
MARKETING
SALES DEPARTMENT
DISTRIBUTION DEPARTMENT
| 11
COMPETITIVENESS
| 12
Manufacturing Cost.
Workforce Skills.
Government and Regulatory Environment.
Macro Factors.
| 13
| 14
Export-led improvement.
| 15
Countries where ARISTOPHARMA products are exported
Singapore
Hong Kong
Sri Lanka
Vietnam
Myanmar
Bhutan
Macau
Ukraine
Mauritius
| 16
WHY EXPORT
PHARMACEUTICAL
PRODUCTS?
| 17
Regulated:
Moderately Regulated:
Unregulated:
| 18
Table 2: Recent Exports by Some Bangladeshi Pharmaceutical Firms
| 19
| 20
Heating, ventilation and air-conditioning (HVAC) systems to ensure no
crosscontamination.
Warehouse.
Validation documentation.
Location:
| 21
Climate:
Economy
Foreign Relations:
Transportation:
Population
Education:
| 22
Health:
Religion:
Ethnic Groups:
Culture:
| 23
Strength
Quality:
Low Price:
Human Resource:
Facilities:
Weaknesses
Corruption:
Political Condition:
Port:
Opportunity
Demand for Imported Pharmaceutical Products:
Cost of Production:
Threats
| 24
Competitors
New possible policies
Corruption:
Nationalists Views:
Counterfeit medicines:
| 25
| 26
Marketing Objectives:
Target Market:
Expected Sales:
Profit Expectations:
Market Penetration and coverage:
Product adaptation or modification
Core Component:
Packaging Component:
Support Service Component:
Promotion Mix
Advertising
Sales promotion:
Personal selling :
Distribution
| 27
Port selection
Mode Selection
Packing
Documentation Required
Insurance Claim
Freight Forwarder
CHANNELS OF DISTRIBUTION
Figure: Distribution channel
Distributor
PRICE DETERMINATION
| 28
TERMS OF SALE
FOB:
FAS:
C&F:
CIF:
| 29
METHODS OF PAYMENT
Cash in Advance:
Open Accounts:
Consignment Sales
Sight Draft:
Time Draft:
Date Draft:
Letter of Credit:
Marketing budget:
| 30
RECOMMENDATION
| 31
IMPROVING PRICE AND QUALITY ON THE
DOMESTIC MARKET
Increase competition
Improve the government’s regulatory function.
Financing.
o Increased regular budget.
o Increased fee revenue.
o Donations.
o Collaboration with the domestic pharmaceutical industry.
Structure.
Some areas to consider are as follows:
o Reviewing regulatory procedures and incentives.
o A reorganization of the regulatory authority.
o Cracking down on corruption.
o Making strategic personnel choices.
o Increasing public involvement.
Level the playing field.
Regulatory Approach.
Transparency Approach.
Involving the private sector in quality control.
| 32
IMPROVING PRICE AND QUALITY ON THE
EXPORT MARKET
Encourage contract manufacturing.
Technical Assistance.
Inspections and GMP certification.
Exporting pharmaceutical products.
Investment and Strategy.
TRIPS.
Government support for firms that export.
Investigation into the feasibility of a bioequivalence laboratory.
Investigation of API production.
The API park
API skill.
| 33
Backward integration.
CONCLUSION:
Bibliography
| 34